Exelixis



Ebit Veränderung Datum
Acadia Pharmaceuticals USD 6.99M 24.66M 2024-12
Agios Pharmaceuticals USD -125037000 22.23M 2024-12
Amgen USD 4.03B 11M 2024-12
AstraZeneca USD 4.2B 119M 2024-12
Bayer EUR 855M 588M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 4.21B 500M 2024-12
Cytokinetics USD -139040000 1.76M 2024-12
Eisai JPY 18.98B 12.87B 2024-03
Eli Lilly USD 5.63B 3.88B 2024-12
Exelixis USD 163.46M 27.38M 2024-12
Genmab DKK 2.16B 58M 2024-12
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Incyte USD 376.26M 121.03M 2024-12
Ionis Pharmaceuticals USD -110000000 38M 2024-12
MacroGenics USD -52837000 107.35M 2024-12
Merck USD 5.22B 339M 2024-12
Moderna USD -1246000000 1.18B 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
Sanofi EUR 2.22B 2.84B 2024-12
Takeda JPY 58B 129.82B 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
Xencor USD -13178000 47.7M 2024-12



Exelixis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.